Download PDF
J Pediatr Infect Dis 2018; 13(01): 046-050
DOI: 10.1055/s-0037-1606565
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Wheeze after Hospitalization for Respiratory Syncytial Virus Infection in Children

Lone Graff Stensballe
1   The Child and Adolescent Clinic 4072, Copenhagen University Hospital “Rigshospitalet”, Copenhagen, Denmark
,
Jacob Simonsen
2   Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
,
Morten Breindahl
3   Department of Neonatology, Copenhagen University Hospital “Rigshospitalet”, Copenhagen, Denmark
,
Louise Winding
4   Department of Paediatrics, Kolding Hospital, Kolding, Denmark
,
Poul-Erik Kofoed
4   Department of Paediatrics, Kolding Hospital, Kolding, Denmark
› Author Affiliations Funding None.
Further Information

Publication History

08 March 2017

04 August 2017

Publication Date:
13 September 2017 (online)

    Permissions and Reprints

Abstract

Introduction Prior studies found associations between respiratory syncytial virus (RSV) infection, wheezing, and asthma. The present study aimed to examine the risk of wheezing after RSV, by the history of wheezing.

Methods We included 39 children hospitalized for RSV infection (cases) and 23 children hospitalized for nonrespiratory tract infection reasons (controls) and followed the children prospectively with regular standardized telephone interviews until 18 months, and again 5 years after inclusion. The risk of wheeze was estimated by odds ratios (OR), comparing children hospitalized for RSV with children hospitalized for other reasons and stratified by wheezing history.

Results Eighteen months after hospitalization for RSV, the adjusted OR of wheezing was 3.16 (95% confidence interval: 0.75–13.3). The effect of hospitalization for RSV on the risk of wheeze was significantly present among children who did not wheeze already before inclusion (adjusted OR: 11.83; 95% confidence interval: 1.12–124.9), while the adjusted OR of wheeze was 0.95 (95% confidence interval: 0.10–9.00) among children who wheezed already before inclusion. The adjusted OR of wheeze after hospitalization for RSV among children who did not wheeze before inclusion was 8.50 (95% confidence interval: 0.79–91.6) 5 years after inclusion.

Conclusion We conclude that the effect of severe RSV infection requiring hospitalization differs according to the history of wheezing, and wanes with time. We recommend that future studies on severe RSV infection and the risk of subsequent wheeze and asthma include information on prior wheeze and asthma.

Keywords

airway hypersensitivity - children - respiratory syncytial virus - wheeze
 

  • References

  • 1 Stensballe LG, Kristensen K, Simoes EA. , et al; Danish RSV Data Network. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics 2006; 118 (05) e1360-e1368
    CrossrefPubMedGoogle Scholar
  • 2 Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. ; Palivizumab Long-Term Respiratory Outcomes Study Group. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126 (02) 256-262
    CrossrefPubMedGoogle Scholar
  • 3 Yoshihara S, Kusuda S, Mochizuki H, Okada K, Nishima S, Simões EA. ; C-CREW Investigators. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics 2013; 132 (05) 811-818
    CrossrefPubMedGoogle Scholar
  • 4 Blanken MO, Rovers MM, Molenaar JM. , et al; Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368 (19) 1791-1799
    CrossrefPubMedGoogle Scholar
  • 5 Kristensen K, Hjuler T, Ravn H, Simões EA, Stensballe LG. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012; 54 (06) 810-817
    CrossrefPubMedGoogle Scholar
  • 6 Welliver RC, Kaul A, Ogra PL. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr 1979; 94 (03) 370-375
    CrossrefPubMedGoogle Scholar
  • 7 Piedimonte G. Respiratory syncytial virus and asthma: speed-dating or long-term relationship?. Curr Opin Pediatr 2013; 25 (03) 344-349
    CrossrefPubMedGoogle Scholar
  • 8 Drysdale SB, Milner AD, Greenough A. Respiratory syncytial virus infection and chronic respiratory morbidity - is there a functional or genetic predisposition?. Acta Paediatr 2012; 101 (11) 1114-1120
    CrossrefPubMedGoogle Scholar
  • 9 Stein RT, Sherrill D, Morgan WJ. , et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354 (9178): 541-545
    CrossrefPubMedGoogle Scholar
  • 10 Nenna R, Ferrara M, Nicolai A. , et al. Viral load in infants hospitalized for respiratory syncytial virus bronchiolitis correlates with recurrent wheezing at thirty-six-month follow-up. Pediatr Infect Dis J 2015; 34 (10) 1131-1132
    CrossrefPubMedGoogle Scholar
  • 11 Stensballe LG, Simonsen JB, Thomsen SF. , et al. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 2009; 123 (01) 131-137.e1
    CrossrefPubMedGoogle Scholar
  • 12 Rossi GA, Colin AA. Respiratory syncytial virus-host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life. Pediatr Allergy Immunol 2017; 28 (04) 320-331
    CrossrefPubMedGoogle Scholar